Antagonists of PD-1 and PD-L1 in Cancer Treatment

Seminars in Oncology
Evan J LipsonSuzanne L Topalian

Abstract

The PD-1 pathway, comprising the immune cell co-receptor Programmed Death 1 (PD-1) and its ligands, PD-L1 (B7-H1) and PD-L2 (B7-DC), mediates local immunosuppression in the tumor microenvironment. Drugs designed to block PD-1 or PD-L1 "release the brakes" on anti-tumor immunity and have demonstrated clinical activity in several types of advanced cancers, validating this pathway as a target for cancer therapy. Two such drugs have recently been approved to treat melanoma and lung cancers, and regulatory approvals in first- and second-line settings for additional cancer types are anticipated. The manageable safety profile of PD-1/PD-L1 blocking drugs identifies them as suitable for outpatient administration and the development of combinatorial therapies. Ongoing studies aim to identify biomarkers to guide patient selection, which would further improve the risk:benefit ratio for these drugs.

References

Jan 17, 2003·The New England Journal of Medicine·Lin ZhangGeorge Coukos
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Junzo HamanishiShingo Fujii
Oct 15, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rezaul KarimSjoerd H van der Burg
Jun 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie R BrahmerSuzanne L Topalian
Sep 8, 2010·The New England Journal of Medicine·Philip W KantoffUNKNOWN IMPACT Study Investigators
Mar 23, 2012·Nature Reviews. Cancer·Drew M Pardoll
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Jun 5, 2012·The New England Journal of Medicine·Julie R BrahmerJon M Wigginton
Nov 22, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Evan J LipsonSuzanne L Topalian
Dec 21, 2012·Expert Review of Anticancer Therapy·Leisha A Emens
Jun 4, 2013·The New England Journal of Medicine·Omid HamidAntoni Ribas
Jun 4, 2013·The New England Journal of Medicine·Jedd D WolchokMario Sznol
Oct 23, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey S WeberY Ann Chen
Mar 5, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Suzanne L TopalianF Stephen Hodi
Mar 25, 2014·Cancer Immunology, Immunotherapy : CII·Anke VanderstraetenFrederic Amant
Apr 10, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Janis M TaubeRobert A Anders
May 21, 2014·Breast Cancer Research and Treatment·S MuenstS D Soysal
Sep 12, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C LebbéJ D Wolchok
Sep 19, 2014·World Journal of Gastrointestinal Oncology·Ambedkar Raj Kulandai VeluIlavarasi Sinduja
Nov 18, 2014·The New England Journal of Medicine·Caroline RobertPaolo A Ascierto
Nov 20, 2014·The New England Journal of Medicine·Alexandra SnyderTimothy A Chan
Dec 3, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerHans J Hammers
Dec 20, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Geoffrey T GibneyJeffrey S Weber

❮ Previous
Next ❯

Citations

Jan 12, 2016·Biomolecules·Tsz-Lun YeungSamuel C Mok
Jan 23, 2016·Current Opinion in Immunology·Olivera J Finn, Pamela L Beatty
Feb 24, 2016·International Journal of Clinical Oncology·Junzo HamanishiIkuo Konishi
Jan 8, 2016·Biochemical and Biophysical Research Communications·Guodong HeYubo Xie
Jan 16, 2016·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Elizabeth ThompsonLeisha A Emens
Mar 15, 2016·Frontiers in Surgery·Seyed-Mostafa RazaviGordon Li
Nov 28, 2015·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Ricarda RauschenbergFriedegund Meier
Mar 11, 2016·The New England Journal of Medicine·Evan J LipsonCharles G Drake
Apr 16, 2016·Nature Reviews. Cancer·Suzanne L TopalianDrew M Pardoll
Jun 5, 2016·Trends in Molecular Medicine·Simona Corso, Silvia Giordano
Aug 18, 2016·Journal for Immunotherapy of Cancer·Leisha A Emens
Nov 2, 2016·Expert Opinion on Biological Therapy·Elham Beyranvand NejadSjoerd H van der Burg
Jan 31, 2017·Annales de pathologie·Michaël DuruisseauxFrédéric Bibeau
May 27, 2017·Journal of Experimental & Clinical Cancer Research : CR·Antonio Carlos de FreitasAldo Venuti
Apr 14, 2017·Current Opinion in Pulmonary Medicine·Vickie R Shannon
Jun 18, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Leisha A EmensFrancesco M Marincola
Jul 22, 2017·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Elizabeth D ThompsonAshley Cimino-Mathews
Jul 29, 2017·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Meixuan ChenKaren S Anderson
Mar 30, 2018·International Journal of Molecular Sciences·Mousumi MajumderPeeyush K Lala
Apr 1, 2018·Liver International : Official Journal of the International Association for the Study of the Liver·Daniel L SuzmanMark I Avigan
Apr 25, 2018·Expert Opinion on Biological Therapy·Debora BasileFabio Puglisi
Jun 4, 2016·Journal of Leukocyte Biology·Anna E VilgelmAnn Richmond
Aug 18, 2018·International Journal of Molecular Sciences·Tomonori Sasahira, Tadaaki Kirita
Aug 23, 2018·Virchows Archiv : an International Journal of Pathology·Thomas Menter, Alexandar Tzankov
May 12, 2019·International Journal of Molecular Sciences·Marilina García-Aranda, Maximino Redondo
Jan 10, 2019·ESMO Open·Yochai Wolf, Yardena Samuels
May 29, 2019·The Journal of Pathology. Clinical Research·Massimo MilioneAndrea Anichini
Aug 9, 2017·Current Treatment Options in Oncology·Russell MaxwellMichael Lim
Oct 23, 2019·Cancer Immunology, Immunotherapy : CII·Marra Jai AghajaniTara Laurine Roberts
Nov 30, 2019·Expert Review of Anticancer Therapy·Shuji Murakami
Jul 17, 2019·The Journal of Clinical Investigation·Karthik SureshFranco D'Alessio
Dec 6, 2019·Current Opinion in Obstetrics & Gynecology·Curtis D ChinJianyu Rao
Sep 7, 2017·Applied Immunohistochemistry & Molecular Morphology : AIMM·Liisa ChangFuju Chang
Mar 4, 2020·Cells·Andrew M K LawDavid Gallego-Ortega
Sep 17, 2017·Oncotarget·Maria ApicellaSilvia Giordano

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Rezaul KarimSjoerd H van der Burg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Michael A PostowJedd D Wolchok
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Mario Sznol, Lieping Chen
© 2021 Meta ULC. All rights reserved